// App-Quantinova.ai

S180 : DARATUMUMAB MAINTENANCE VS OBSERVATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH BORTEZOMIB, THALIDOMIDE, AND DEXAMETHASONE ± DARATUMUMAB AND ASCT: CASSIOPEIA PART 2 RESULTS

Researchers

Presenter

  • Philippe Moreau

Principal Investigators

  • Aurore Perrot

  • Bertrand Arnulf

  • Karim Belhadj

  • Lotfi Benboubker

  • Marie Bn

  • Sonja Zweegman

  • Hlne Caillon

  • Denis Caillot

  • Jill Corre

  • Michel Delforge

  • Thomas Dejoie

  • Chantal Doyen

  • Thierry Facon

  • Ccile Sonntag

  • Jean Fontan

  • Laurent Garderet

  • Kon-Siong Jie

  • Lionel Karlin

  • Frdrique Kuhnowski

  • Jrme Lambert

  • Xavier Leleu

  • Margaret Macro

  • Murielle Roussel

  • Anne-Marie Stoppa

  • Niels W C J van de Donk

  • Soraya Wuillme

  • Annemiek Broijl

  • Cyrille Touzeau

  • Mourad Tiab

  • Jean-Pierre Marolleau

  • Nathalie Meuleman

  • Marie-Christiane Vekemans

  • Matthijs Westerman

  • Saskia Klein

  • Mark-David Levin

  • Fritz Offner

  • Martine Escoffre-Barbe

  • Jean-Richard Eveillard

  • Reda Garidi

  • Tahamtan Ahmadi

  • Maria Krevvata

  • Ke Zhang

  • Carla de Boer

  • Sanjay Vara

  • Tobias Kampfenkel

  • Veronique Vanquickelberghe

  • Jessica Vermeulen

  • Herv Avet-Loiseau

  • Pieter Sonneveld

Medical Centers

  • Institut Curie Site Paris, Paris, France

  • Hospital Saint Antoine, Paris, France

  • Erasmus MC Cancer Center, Rotterdam, Netherlands

  • Bordeaux University Hospital, ISPED, Bordeaux, France

  • Genmab,Princeton, NJ,United States

  • Institut Paoli-Calmettes, Marseille, France

  • Development, LLC,High Wycombe,United Kingdom

  • Amiens University Hospital, Amiens, France

  • Development, LLC,La Jolla,United States

  • Uiniversity Hospital Minjoz, Besancon, France

  • Hopital Claude Huriez, Lille, France

  • University Hospital Gent, Gent, Belgium

  • Development, Leiden, Netherlands

  • Dijon University Hospital, Hôpital du Bocage,Dijon,France

  • Development,Beerse,Belgio

  • Universite Catholique de Louvain Cliniques Universitaires St-Luc, Brussels, Belgium

  • University Hospitals Leuven and KU Leuven, Leuven, Belgium

  • DGOG, Meander Medical Center, Amersfoort, Netherlands

  • Centre Hospitalier Departemental Vendee, La Roche-Sur-Yon, France

  • University Hospital,Rennes,France

  • Saint-Quentin Hospital Center,Saint Quentin,France

  • Poitiers University Hospital, CHU la Milétrie,Poitiers,France

  • Janssen Research &amp

  • Northwest Clinics Alkmaar, Alkmaar, Netherlands

  • Albert Schweitzer Ziekenhuis, Dordrecht, Netherlands

  • Development, LLC,Spring House,United States

  • Lyon Sud University Hospital, Pierre-Benite, France

  • Physics, Vrije Universiteit Amsterdam, Amsterdam, Netherlands

  • Universite catholique de Louvain, CHU UCL Namur, Namur, Belgium

  • Zuyderland Hospital, Sittard, Netherlands

  • Hospital Saint Antoine, Paris, France

  • Centre Hospitalier Annecy Genevois, Pringy, France

  • Sorbonne Universites, Paris, France

  • Nantes University Hospital, Nantes, France

  • Tours University Hospital, Hôpital de Bretonneau,Tours,France

  • Rennes University Hospital, Hôpital de Pontchaillou,Rennes,France

  • University Hospital Hotel-Dieu, Nantes, France

  • Institut Jules Bordet, Universite libre de Bruxelles, Brussels, Belgium

  • Brest University Hospital, Hôpital A. Morvan,Brest,France

  • Hôpital Henri Mondor, Créteil, France,

  • Institut Universitaire du Cancer de Toulouse, Toulouse, France

  • Nantes University Hospital, Nantes, France

  • Unite de Genomique du Myelome, IUCT-oncopole, Toulouse, France

  • Hopital Hautepierre, Strasbourg, France

Locations

  • France

  • Netherlands

  • United States

  • United Kingdom

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • daratumumab Intravenous

  • Thalidomide

  • Bortezomib

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved